CGON News

US IPO Market's Green Shoots Take Root In the first quarter of 2024, the IPO market's green shoots grew further, with 30 IPOs raising a combined $7.8 billion. While deal count was in line with the 1Q23, proceeds more than tripled, thanks to the continued return of larger offerings. Fifteen US IPOs raised $100 million...read more

Eleven IPOs raised a combined $3.8 billion in January, the busiest month for both $100+ million and $1+ billion IPOs since late 2021. Six offerings raised $100 million or more, led by two billion-dollar deals: sports gear maker Amer Sports (AS) and Kazakhstani "super app" Kaspi.kz (KSPI). Remaining activity came from small, primarily China-based...read more

Seven IPOs priced this past week, led by three that raised $100+ million. After upwardly revising the terms earlier in the week, CG Oncology (CGON) further upsized the offering and priced above the range to raise $380 million at a $1.3 billion market cap. Its sole clinical asset is initially in development for a subclass of bladder cancer and is currently in an...read more

CG Oncology, a Phase 3 biotech developing an oncolytic immunotherapy for bladder cancer, raised $380 million by offering 20 million shares at $19, above the range of $16 to $18. The company offered 3 million more shares than anticipated. It originally planned to offer 11.8 million shares before upwardly revising the terms on Tuesday. CG Oncology's candidate cretostimogene is...read more